What is NDC 0002-1220?

0002-1220 is the product NDC for Tauvid (flortaucipir f-18), Flortaucipir f-18 100 mCi/mL injection, solution, listed with the FDA by Eli Lilly and Company. It has 2 package NDCs, shown above in 10- and 11-digit form.

Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tauvid?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tauvid NDC 0002-1220 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0002-1220Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00002-1220Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0002-1220-48	00002122048	1 VIAL, MULTI-DOSE in 1 CAN (0002-1220-48) / 100 mL in 1 VIAL, MULTI-DOSEMarketed from Oct 25, 2022
0002-1220-50	00002122050	1 VIAL, MULTI-DOSE in 1 CAN (0002-1220-50) / 50 mL in 1 VIAL, MULTI-DOSEMarketed from Oct 25, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tauvid
Generic name (nonproprietary): flortaucipir f-18
Active ingredients: Flortaucipir f-18 — 100 mCi/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Eli Lilly and CompanyNDC labeler code 0002
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 212123
Marketing start: Jul 1, 2022
Listing expires: Dec 31, 2027
Identifiers: Product ID 0002-1220_28ed503a-b3ed-40a3-a6e8-acdf613fa748SPL ID 28ed503a-b3ed-40a3-a6e8-acdf613fa748SPL set ID b483abad-5230-462a-adfb-1a65160f01d0UNII T1JP1KYU9O

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400002122048 followed by a unit qualifier and the quantity

Package 00002-1220-48. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 30, 2025.

Indications (excerpt from the label)

TAUVID is indicated for use with positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD). TAUVID is a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD). ( 1 ) Limitations of Use TAUVID is not indicated for use in the evaluation of patients for chronic traumatic encephalopathy …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0002-1220

What is NDC 0002-1220?: 0002-1220 is the product NDC for Tauvid (flortaucipir f-18), Flortaucipir f-18 100 mCi/mL injection, solution, listed with the FDA by Eli Lilly and Company. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tauvid (Flortaucipir F-18).
What is the active ingredient?: Flortaucipir f-18.
Who is the labeler?: Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tauvid?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Tauvid (Flortaucipir f-18) NDC 0002-1220